LGRRX
Price
$29.26
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Net Assets
17.85B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

LGRRX vs RGEBX

Header iconLGRRX vs RGEBX Comparison
Open Charts LGRRX vs RGEBXBanner chart's image
Loomis Sayles Growth A
Price$29.26
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets17.85B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
LGRRX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LGRRX vs. RGEBX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGRRX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. LGRRX (17.9B). LGRRX (0.00) and RGEBX (0.00) have matching dividends . LGRRX was incepted earlier than RGEBX: LGRRX (29 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than LGRRX (0.92). RGEBX is a more actively managed with annual turnover of: 25.00 vs. LGRRX (10.00). RGEBX has a lower initial minimum investment than LGRRX: RGEBX (250) vs LGRRX (2500). LGRRX annual gain was more profitable for investors over the last year : 21.46 vs. RGEBX (17.32). LGRRX (39.33) and RGEBX (38.39) have equivalent 5 years return.
LGRRXRGEBXLGRRX / RGEBX
Total Expense Ratio0.911.0983%
Annual Report Gross Expense Ratio0.921.0984%
Fund Existence29 years11 years-
Gain YTD11.00215.13273%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets17.9B332B5%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.4617.32124%
Returns for 3 years64.4757.24113%
Returns for 5 years39.3338.39102%
Returns for 10 years193.5191.00213%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
ARCT17.851.09
+6.50%
Arcturus Therapeutics Holdings
MANH215.315.45
+2.60%
Manhattan Associates
TRMD23.020.25
+1.10%
TORM plc
INDP3.30-1.31
-28.35%
Indaptus Therapeutics Inc